The pre-closing loan signals strong conviction in the NOMAD acquisition and provides NOMAD with capital to execute on its order backlog. Traders should watch for merger closing around July 1, 2026 — success would transform LIXT from a pre-revenue biotech into an energy storage company. The recent dilutive offering funded this loan, so net cash impact is neutral. If the merger fails, LIXT has a secured claim with 15% interest, limiting downside.
Price Chart
Executive Summary
LIXTE Biotechnology issued a $6.5 million secured promissory note to NOMAD Transportable Power Systems, the target of its previously announced merger, to pay off NOMAD's existing debt and fund working capital ahead of the expected July 1, 2026 closing. The loan carries 15% interest, is secured by all NOMAD assets, and will be offset against merger consideration at closing. This filing demonstrates LIXT's commitment to the transformative acquisition and de-risks NOMAD's near-term operations, but comes just two weeks after a dilutive $16.6M equity offering that provided the cash.
Key Financial Metrics
Key Facts
- LIXT loaned $6.5 million to NOMAD via a secured promissory note dated June 17, 2026
- Loan proceeds: repay NOMAD's Bay Point Capital debt (amount undisclosed) and provide working capital
- Note bears 15% interest, matures 30 days from issuance with automatic 30-day extensions while merger agreement is active
- Upon merger closing, the outstanding principal and interest will be offset against amounts due to NOMAD under the merger agreement
- If merger terminates due to LIXT breach, repayment due in 6 months; if NOMAD breach, due in 3 days
- Merger expected to close on or about July 1, 2026; combined company to be renamed NOMAD Power Solutions, Inc. with new ticker
- LIXT raised ~$16.6M in a registered direct offering on June 4, 2026 at a ~10.4% discount, representing ~19% dilution
Financial Impact
$6.5 million loan, secured by all NOMAD assets, to be offset at merger close
Risk Factors
- Merger fails to close, requiring LIXT to collect on the note from NOMAD (which may have limited liquidity)
- Recent 19% dilution from June 4 offering weighs on existing shareholders
- LIXT remains pre-revenue with a going-concern qualification; cash used for loan could have funded clinical programs
- New ticker and business focus may cause index/ETF rebalancing and investor turnover
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-029308 |
| Exhibit: ex99-1.htm | 0001493152-26-029308 |
| Document: form8-k.htm | 0001493152-26-029308 |
| Document: 0001493152-26-029308-index-headers.html | 0001493152-26-029308 |
| Document: 0001493152-26-029308-index.html | 0001493152-26-029308 |
| Document: 0001493152-26-029308.txt | 0001493152-26-029308 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jul 2, 2026 16w ago | 8-K | $7.29 | awaiting T+1 | — | — |
Jun 18, 2026 18w ago | 8-K | $7.48 $7.30 | ▼ −2.41% | ▼ −0.95% | — |
Jun 16, 2026 19w ago | 8-K | $6.96 $7.61 | ▲ +9.34% | ▲ +8.56% | — |
Jun 12, 2026 19w ago | Press Release | $6.19 $6.72 | ▲ +8.56% | ▲ +6.80% | — |
Jun 4, 2026 20w ago | 8-K | $7.00 $6.65 | ▲ +5.00% | ▲ +5.23% | — |
Jun 4, 2026 20w ago | 424B5 | $7.00 $6.65 | ▲ +5.00% | ▲ +5.23% | — |
Jun 1, 2026 21w ago | 8-K | $7.21 $7.04 | ▼ −2.36% | ▼ −2.50% | — |
May 14, 2026 23w ago | Press Release | $5.16 $4.70 | ▼ −8.91% | ▼ −8.85% | — |
Apr 17, 2026 27w ago | 8-K | $3.44 $3.48 | ▲ +1.16% | ▲ +1.82% | — |
Apr 13, 2026 28w ago | Press Release | $2.93 $2.91 | ▼ −0.68% | ▼ −1.89% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers